Hypoparathyroidism
|
Inheritance
|
Gene mutation
|
Clinical features
|
Autoimmune
|
Autoimmune polyglandular hypoparathyroidism
|
Autoimmune polyendocrine syndrome type 1
|
Autosomal recessive
|
Mutation in AIRE gene
|
|
Isolated
|
Familial Isolated hypoparathyroidism
|
Autosomal dominant
|
PTH gene
|
- Clinical features of hypocalcemia including:
|
GCM2 gene
|
|
Autosomal recessive
|
PTH gene
|
- Clinical features of hypocalcemia including:
|
Glial cell missing 2 (GCM2) gene[1]
|
- Clinical features of hypocalcemia including:
|
X-linked
|
FHL1 gene (exon 4, c.C283T, p.R95W) on chromosome locus Xq26-q27.
|
- Clinical features of hypocalcemia including:
|
Autosomal dominant hypercalcemia
|
Autosomal dominant hypocalcemia type 1
|
Autosomal dominant
|
Calcium-sensing receptor gene mutation
|
- Calcium-sensing receptor gene activating mutation.
- Most common genetic form of hypoparathyroidism.
- Also known as familial hypercalciuric hypocalcemia.
- The activating mutation results in gain in function.
- Calcium-sensing receptor gene activating mutation can also cause mild Bartter syndrome type 5. This mutation cause the inhibition of apical potassium channel in the thick ascending limb of the loop of Henle in the kidney.
|
Autosomal dominant hypocalcemia type 2
|
Autosomal dominant
|
G protein G11 (GNA11) mutation
|
- Clinical features of hypocalcemia including:
|
Congenital multisystem syndromes
|
DiGeorge syndrome
|
Autosomal dominant
|
22q11.2 deletion.
|
- Presents with thymus dysfunction, cardiac defects, immunodeficiency, hypocalcemia, and other clinical problems.
- Also known as 22q11.2DS, CATCH 22 syndrome, Cayler cardiofacial syndrome, conotruncal anomaly face syndrome (CTAF), deletion 22q11.2 syndrome, Sedlackova syndrome, Shprintzen syndrome, VCFS, velocardiofacial syndrome, and velo-cardio-facial syndrome.
- CATCH 22 stands for cardiac defects, abnormal facies, thymic aplasia, cleft palate, and hypocalcemia with 22q11.2 deletion.
|
CHARGE syndrome
|
Autosomal dominant
|
CHD7 G744S missense mutation
|
|
Kenny-Caffey syndrome type 1
|
Autosomal recessive
|
Deletion of the TBCE gene
|
|
Kenny-Caffey syndrome type 2
|
Autosomal dominant
|
Mutation of “family with sequence similarity 111, member A″ (FAM111A) gene located on chromosome locus 11q12.1
|
- Patients with Kenny-Caffey sundrome type 2 have same clinical features as Kenny-Caffey syndrome type 1 except for mental retardation.
|
Sanjad-Sakati syndrome
|
Autosomal recessive
|
Mutation in TBCE gene.
|
|
Barakat syndrome
|
Autosomal recessive
|
Mutations in the GATA3 gene
|
- Also known as hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.
- Presents with primary hypoparathyroidism, nerve deafness, steroid-resistant nephrosis.
|
Metabolic diseases
|
Mitochondiral polyneuropathies
|
Kearns–Sayre syndrome
|
Mitochondrial inheritence
|
mtDNA deletion
|
|
Maternally inherited diabetes and deafness (MIDD)
|
Mitochondrial inheritence
|
MT‑TL1 defect
|
|
Mitochondrial enzyme deficiencies
|
Mitochondrial trifunctional protein deficiency (MTP deficiency)
|
Autosomal recessive
|
HADHA or HADHB gene mutation
|
- Clinical features of mitochondrial trifunctional protein deficiency occurring during infancy include:
- Infants with mitochondrial trifunctional protein deficiency are also at increased risk for:
- Clinical features of mitochondrial trifunctional protein deficiency occurring after infancy include:
|
Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHAD deficiency)
|
Autosomal recessive
|
G1528C gene mutation
|
|
Heavy metal storage disorders
|
Hemochromatosis
|
Autosomal recessive
|
HFE gene mutation
|
|
Wilson's disease
|
Autosomal recessive
|
ATP7B gene mutation
|
|